If the tumor is already inoperable or shows borderline resectability, mTOR inhibitor treatment should be considered—after confirming immunohistochemical positivity for p70S6K—as this may provide a chance to perform resection after the shrinkage of the tumor. Here, MTOR is linked to neoplasm.